|
FR2686087A1
(fr)
|
1992-01-13 |
1993-07-16 |
Inst Nat Sante Rech Med |
Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications.
|
|
US5633149A
(en)
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
|
US6692920B1
(en)
|
1994-12-07 |
2004-02-17 |
Incyte Corporation |
Antibodies to a chemokine expressed in inflamed adenoid
|
|
WO1996039522A1
(en)
|
1995-06-05 |
1996-12-12 |
Human Genome Sciences, Inc. |
Human chemokine beta-11 and human chemokine alpha-1
|
|
WO1998011226A2
(en)
|
1996-09-10 |
1998-03-19 |
Schering Corporation |
Mammalian chemokines, related reagents
|
|
US6852508B1
(en)
|
1997-02-28 |
2005-02-08 |
Genetics Institute, Llc |
Chemokine with amino-terminal modifications
|
|
US6110695A
(en)
|
1997-12-02 |
2000-08-29 |
The Regents Of The University Of California |
Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
|
|
US6723538B2
(en)
|
1999-03-11 |
2004-04-20 |
Micromet Ag |
Bispecific antibody and chemokine receptor constructs
|
|
EP1268554A2
(de)
|
2000-03-31 |
2003-01-02 |
IPF Pharmaceuticals GmbH |
Diagnostik- und arzneimittel zur untersuchung des zelloberflächenproteoms von tumor- und entzündungszellen sowie zur behandlung von tumorerkrankungen und entzündlichen erkrankungen vorzugsweise mit hilfe einer spezifischen chemokinrezeptor-analyse und der chemokinrezeptor-ligand-interaktion
|
|
GB2361003A
(en)
|
2000-04-07 |
2001-10-10 |
Astrazeneca Ab |
Novel compounds
|
|
US7052676B2
(en)
|
2000-09-26 |
2006-05-30 |
The Regents Of The University Of Michigan |
Methods for inhibition of HIV replication using a small molecule inhibitor
|
|
JP2004517078A
(ja)
|
2000-12-01 |
2004-06-10 |
シェーリング コーポレイション |
哺乳動物遺伝子および関連試薬の使用
|
|
US6818406B2
(en)
|
2001-03-23 |
2004-11-16 |
Mayo Foundation For Medical Education And Research |
Rheumatoid arthritis markers
|
|
US7442512B2
(en)
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
DE60334453D1
(de)
|
2002-05-30 |
2010-11-18 |
Macrogenics Inc |
Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten
|
|
US20070185017A1
(en)
|
2002-10-29 |
2007-08-09 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US7919083B2
(en)
|
2002-11-15 |
2011-04-05 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
|
|
AU2003294290A1
(en)
|
2002-11-15 |
2004-06-15 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
|
|
EP1572116A4
(en)
|
2002-11-26 |
2007-12-12 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
|
|
EP1613657A2
(en)
|
2003-03-28 |
2006-01-11 |
Centocor, Inc. |
Anti-amyloid antibodies, compositions, methods and uses
|
|
AU2005243730B2
(en)
|
2004-04-12 |
2010-05-27 |
Genvec, Inc. |
Method of using adenoviral vectors to induce an immune response
|
|
CA2501422C
(en)
|
2004-04-29 |
2014-08-12 |
University Of Rochester |
Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
|
|
CN1842540B
(zh)
|
2004-07-09 |
2012-07-04 |
中外制药株式会社 |
抗-磷脂酰肌醇蛋白聚糖3抗体
|
|
BRPI0518994A2
(pt)
|
2004-12-31 |
2008-12-02 |
Biogen Idec Inc |
anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
|
|
EP3479844B1
(en)
|
2005-04-15 |
2023-11-22 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
|
WO2006117910A1
(ja)
|
2005-04-28 |
2006-11-09 |
Mochida Pharmaceutical Co., Ltd. |
抗血小板膜糖蛋白質ⅵモノクローナル抗体
|
|
WO2007064911A1
(en)
|
2005-12-02 |
2007-06-07 |
Biogen Idec Inc. |
Anti-mouse cd20 antibodies and uses thereof
|
|
GB0607774D0
(en)
|
2006-04-20 |
2006-05-31 |
Renovo Group Plc |
Medicaments
|
|
WO2007124414A2
(en)
|
2006-04-21 |
2007-11-01 |
Centocor, Inc. |
Cxcl13 antagonists and their use for the treatment of inflammatory diseases
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US20080199481A1
(en)
|
2007-02-21 |
2008-08-21 |
Astrazeneca Ab |
Compounds
|
|
WO2008121940A1
(en)
|
2007-03-30 |
2008-10-09 |
Centocor, Inc. |
Cxcl13 antagonists and their use for the treatment of inflammatory diseases
|
|
US20110300167A1
(en)
|
2008-11-04 |
2011-12-08 |
Mcmurry Thomas J |
Cxcr5 receptor compounds
|
|
AU2011295902B2
(en)
|
2010-09-02 |
2014-12-04 |
Vaccinex, Inc. |
Anti-CXCL13 antibodies and methods of using the same
|
|
US20130310582A1
(en)
*
|
2011-02-04 |
2013-11-21 |
Dow Global Technologies Llc |
Process for removing iron ions from an organic stream
|
|
CN104114187A
(zh)
|
2011-12-28 |
2014-10-22 |
诺沃姆德治疗公司 |
去糖基化的人类抗体、其融合蛋白质及用途
|
|
NZ629828A
(en)
|
2012-03-02 |
2017-05-26 |
Vaccinex Inc |
Methods for the treatment of b cell-mediated inflammatory diseases
|
|
BR112015021964A2
(pt)
|
2013-03-08 |
2017-08-29 |
Vaccinex Inc |
Anticorpo isolado ou um fragmento ligante de antígenos do mesmo que se liga especificamente a cxcl13, composição e seus usos
|